PAS
ATYR

Point72 Asia (Singapore)’s aTyr Pharma ATYR Stock Holding History

Point72 Asia (Singapore)’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,255
Closed -$3.79K – 1314
2025
Q1 		$3.79K Buy
1,255
+21
+2% +$77 ﹤0.01% 789
2024
Q4 		$4.47K Buy
+1,234
New +$3.74K ﹤0.01% 795

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asia (Singapore)'s ATYR Position: Q2 2025 in Review

Point72 Asia (Singapore) sold out of aTyr Pharma (ATYR) in Q2 2025, closing a stake of 1,255 shares — an estimated $3.79K sold.

Point72 Asia (Singapore) first reported a position in ATYR in Q4 2024 and held it in 2 quarters. The position peaked at $4.47K in Q4 2024. 110 funds tracked by Wall St. Rank hold ATYR as of Q2 2025.

  • Point72 Asia (Singapore) reported no remaining aTyr Pharma position as of Q2 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 1,255 aTyr Pharma shares in Q2 2025, an estimated $3.79K.
  • Point72 Asia (Singapore) first reported a position in aTyr Pharma in Q4 2024 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s aTyr Pharma position peaked at $4.47K in Q4 2024.
  • 110 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.